摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(4-Isopropylsulfanyl-benzoyl)-[1,4']bipiperidinyl-1'-carboxylic acid tert-butyl ester | 203187-11-5

中文名称
——
中文别名
——
英文名称
4-(4-Isopropylsulfanyl-benzoyl)-[1,4']bipiperidinyl-1'-carboxylic acid tert-butyl ester
英文别名
tert-butyl 4-[4-(4-propan-2-ylsulfanylbenzoyl)piperidin-1-yl]piperidine-1-carboxylate
4-(4-Isopropylsulfanyl-benzoyl)-[1,4']bipiperidinyl-1'-carboxylic acid tert-butyl ester化学式
CAS
203187-11-5
化学式
C25H38N2O3S
mdl
——
分子量
446.654
InChiKey
CXRSCQDUBIPYBX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    561.9±50.0 °C(predicted)
  • 密度:
    1.14±0.1 g/cm3(Temp: 20 °C; Press: 760 Torr)(predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    5.48
  • 重原子数:
    31.0
  • 可旋转键数:
    5.0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.68
  • 拓扑面积:
    49.85
  • 氢给体数:
    0.0
  • 氢受体数:
    5.0

反应信息

  • 作为反应物:
    描述:
    4-(4-Isopropylsulfanyl-benzoyl)-[1,4']bipiperidinyl-1'-carboxylic acid tert-butyl ester 在 sodium tetrahydroborate 作用下, 以 甲醇 为溶剂, 以98%的产率得到4-[Hydroxy-(4-isopropylsulfanyl-phenyl)-methyl]-[1,4']bipiperidinyl-1'-carboxylic acid tert-butyl ester
    参考文献:
    名称:
    Sulfide analogues as potent and selective M 2 muscarinic receptor antagonists
    摘要:
    We have discovered highly potent, selective sulfide M-2 receptor antagonists with low molecular weight and different structural features compared with our phase I clinical candidate Sch 211803. Analogue 30 showed superior M-2 receptor selectivity profile over Sch 211803. More importantly, this study provided new leads for the discovery of M-2 receptor antagonists as potential drug candidates. (C) 2002 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0960-894x(02)00096-3
  • 作为产物:
    参考文献:
    名称:
    Sulfide analogues as potent and selective M 2 muscarinic receptor antagonists
    摘要:
    We have discovered highly potent, selective sulfide M-2 receptor antagonists with low molecular weight and different structural features compared with our phase I clinical candidate Sch 211803. Analogue 30 showed superior M-2 receptor selectivity profile over Sch 211803. More importantly, this study provided new leads for the discovery of M-2 receptor antagonists as potential drug candidates. (C) 2002 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0960-894x(02)00096-3
点击查看最新优质反应信息